NuScale Power Corporation research snapshot
SMR AI stock analysis as of the August 4, 2026 data cutoff reads NuScale Power Corporation as a high-risk, pre-revenue small modular reactor developer with a strong balance sheet and a large drawdown. The stock closed at $9.01 on August 3, 2026, up 0.59 or 7.01% from the $8.42 close on July 31, after opening at $8.47 and trading in a session range of $8.29 to $9.13, with an after-hours quote of $9.05, up 0.04 or 0.44%, carrying a market capitalization near $3.29 billion, matching the $9.01 price times 365.48 million shares outstanding, while the Q1 2026 Form 10-Q lists 323,741,458 Class A shares and 19,375,371 Class B shares outstanding as of March 31, 2026. The stock is down about 79.7% over the trailing 52 weeks after peaking near $57.42, TTM revenue is $18.67 million down 61.9%, the TTM net loss is $385.80 million, and the company held about $890 million of cash and short-term investments as of March 31, 2026 with total liquidity near $1.0 billion rising above $1.2 billion by early May. The main decision point is whether TVA and ENTRA1 power purchase agreement progress, RoPower financing, and the August 5, 2026 Q2 report can offset heavy at-the-market dilution, a securities class action, and declining revenue. This is informational research and not investment advice.
Current price
$9.01 at the August 3, 2026, 4:00 PM EDT market close, up 0.59 or 7.01% from the $8.42 July 31 close, after opening at $8.47 and trading in a session range of $8.29 to $9.13 on the real-time quote, with an after-hours quote of $9.05, up 0.04 or 0.44%
Market cap
$3.29 billion, reported by StockAnalysis.com at the August 3 market close and matching the $9.01 price times 365.48 million shares outstanding; the Q1 2026 Form 10-Q cover lists 323,741,458 Class A shares and 19,375,371 Class B shares outstanding as of March 31, 2026, before later at-the-market sales
AI score
45 / 100
Rating
High-risk pre-revenue nuclear option
Trend status
Oversold bounce below key moving averages, with Q2 2026 earnings due August 5, 2026
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | NuScale develops small modular reactor technology for clean 24/7 baseload power. It is pre-revenue at scale: TTM revenue of $18.67 million is down 61.9% year over year, Q1 2026 revenue was $0.565 million, and commercial deployment still depends on the TVA and ENTRA1 project and the RoPower project. | Medium |
| Moat | Moat potential comes from NRC standard design approval for 50 MW and 77 MW modules under 10 CFR Part 52, the only SMR with full NRC design approval, a compact behind-the-meter emergency planning zone, available low-enriched uranium fuel through Framatome, factory modular fabrication with Doosan Enerbility, and first-mover credibility. The moat is real on paper but not yet proven by commercial earnings. | Medium |
| Management | Management is led by President and CEO John Hopkins, CFO Ramsey Hamady, and co-founder and CTO Jose Reyes. They have kept about $1.0 to $1.2 billion of liquidity and target operational cash flow positive by end of 2026, but the company faces a securities class action and a derivative suit over ENTRA1 disclosures. | Medium |
| Financial trend | Revenue is declining and losses are large: TTM net loss of $385.80 million, FY2025 net loss of $355.79 million versus $136.62 million in FY2024, and Q1 2026 net loss of $46.7 million. The balance sheet is strong with $890.13 million of cash and short-term investments and no material debt, but shares outstanding rose 101.11% year over year from at-the-market dilution. | Medium-low |
| Valuation | Valuation is option-like because earnings do not anchor the case. The stock trades at about 176.39x TTM sales and 2.50x book value, with net cash near $2.42 per share on the current share count, and an analyst average price target of $14.57. | Medium-low |
| Technical trend | Price is in a long downtrend, down 79.72% over 52 weeks to $9.01, below the 50-day moving average near $9.94 and the 200-day near $16.25, but above the 5-day and 20-day averages near $8.37 and $8.45 after an oversold bounce, with 14-day RSI near 50.73. | Medium |
| Risk level | Risk is high. The thesis can fail if the TVA and ENTRA1 PPA is delayed or cancelled, RoPower financing is not secured, at-the-market dilution continues, litigation expands, revenue keeps falling, or cash burn outruns the liquidity buffer. | High |
| AI confidence | High for descriptive facts and cross-checked math across StockAnalysis.com, Macrotrends, SEC EDGAR XBRL, the Q1 2026 Form 10-Q, and the Q1 2026 earnings call. Lower for forward project revenue and price targets. | Medium-high |
| Investment certainty | Low certainty because the page gives a framework and scenario ranges, not a personalized buy or sell instruction. | Low |
SMR AI stock forecast
The SMR AI stock forecast uses scenario ranges around the $9.01 August 3, 2026 close rather than a point target. The framework is anchored to the analyst consensus average target of $14.57, with a low of $6.00, a median of $13.00, and a high of $25.00 across 18 analysts, and the base, bullish, and bearish areas depend on project milestones, dilution, and sentiment rather than current earnings.
$12 to $18
More likely if the TVA and ENTRA1 power purchase agreement is finalized, RoPower pre-EPC financing is secured, the August 5, 2026 Q2 report shows project progress, nuclear policy tailwinds continue, and the stock reclaims and holds the 50-day moving average near $9.94.
$7.50 to $11.50
More likely if project discussions continue without a binding PPA, revenue stays lumpy and small, dilution continues through the at-the-market program, and the stock trades in a wide range between the 52-week low zone and the 50-day moving average.
$5 to $7.50
More likely if financing slips, litigation expands, the at-the-market program dilutes further, nuclear sector sentiment cools, or the stock breaks the 52-week low near $7.21, which would point toward the analyst low target of $6.00 and the Citi target of $7.50.
SMR AI technical analysis
SMR AI technical analysis is mixed as of the August 4, 2026 data cutoff. The stock closed at $9.01 on August 3, 2026, up 7.01%, after a roughly 80% drawdown from the 52-week high of $57.42 to a low of $7.21. It sits above the 5-day and 20-day moving averages near $8.37 and $8.45, below the 50-day moving average near $9.94, and well below the 200-day moving average near $16.25, with 14-day RSI near 50.73. The 5-day and 20-day averages were computed from the StockAnalysis.com daily price history, and the 50-day and 200-day values come from the StockAnalysis.com statistics page.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $9.01 | StockAnalysis.com real-time quote at the August 3, 2026, 4:00 PM EDT market close, up 0.59 or 7.01% from the $8.42 July 31 close after opening at $8.47 and trading in a session range of $8.29 to $9.13; the after-hours quote was $9.05, up 0.04 or 0.44%. |
| 5-day moving average | $8.37 | Computed as the simple average of the five closing prices through August 3, 2026 in the StockAnalysis.com daily price history, just below the current price. |
| 20-day moving average | $8.45 | Computed as the simple average of the twenty closing prices through August 3, 2026 in the StockAnalysis.com daily price history, a nearby support reference for pullbacks. |
| Near support | $8.29 to $8.45 | The August 3 day low near $8.29 plus the 20-day moving average zone; a break would open the $7.59 to $7.72 area from late July. |
| Next support | $7.21 to $7.59 | The 52-week low zone set in July 2026, a key level for the downtrend. |
| Near resistance | $9.94 to $10.50 | The 50-day moving average plus the early July trading range; a close above this zone would improve the short-term picture. |
| Next resistance | $12 to $14 | The June trading zone and roughly the median analyst target area, with the 200-day moving average near $16.25 far overhead. |
| 50-day moving average | $9.94 | StockAnalysis.com statistics reported the 50-day moving average near $9.94 on August 3, 2026, above the current price. |
| 200-day moving average | $16.25 | StockAnalysis.com statistics reported the 200-day moving average near $16.25 on August 3, 2026, well above the current price and confirming the longer-term downtrend. |
| Momentum | RSI near 50.7 | The 14-day RSI was near 50.73 on StockAnalysis.com statistics on August 3, 2026, neutral after the oversold bounce from the $7.21 low. |
| Volume | About 29.6 million average shares | StockAnalysis.com statistics listed 20-day average volume near 29.6 million shares on August 3, 2026; the average of the last twenty daily volumes in the price history was near 29.6 million shares, and the August 3 session showed about 27.6 million shares traded at the close. |
| Volatility | Very high | Beta is 2.25 and the 20-day realized volatility computed from the StockAnalysis.com daily closing price history was roughly 95% annualized as of August 3, 2026, so position sizing must tolerate very large daily moves, especially around the August 5, 2026 earnings report. |
| Invalidation | Close below $7.59 | A daily close below $7.59, and especially below the $7.21 low, would confirm the downtrend; for the short-term setup, a close below the 20-day moving average near $8.45 would weaken the bounce. |
SMR AI trading strategy
The SMR AI trading strategy is a rules-based research framework for a high-volatility, pre-revenue nuclear stock. It is not personal advice and should be paired with fresh chart data, filings, position sizing, and a defined invalidation level, especially with Q2 2026 earnings due August 5, 2026.
Wait for SMR to reclaim and hold the 50-day moving average near $9.94 on rising volume, then monitor a push toward the $12 to $14 zone.
A daily close back below the 20-day moving average near $8.45 or a failed break of $9.94 should trigger a stop and review.
If SMR pulls back toward the $8.29 to $8.45 support band without a thesis break, compare price action with the August 5, 2026 earnings report, TVA PPA news, and at-the-market dilution data before acting.
Do not average down without a maximum loss rule because a pre-revenue stock can keep falling if project financing or sentiment turns.
Track the TVA and ENTRA1 power purchase agreement, RoPower pre-EPC financing, revenue and cash burn in the August 5 Q2 report, at-the-market share sales and the roughly $962 million of remaining 2026 ATM capacity, litigation developments, and the $1.0 to $1.2 billion liquidity position.
Reduce confidence when price moves are driven by headlines without matching project or financial evidence.
Investment research summary
NuScale sells small modular reactor technology, licensing, engineering, and deployment services. Customers pay for a path to clean 24/7 baseload power for utilities, industrial users, and data center demand, but revenue today is small and milestone-based rather than recurring product sales.
The moat is built on NRC standard design approval for 50 MW and 77 MW modules under 10 CFR Part 52, the only SMR with full NRC design approval, a compact behind-the-meter emergency planning zone, available low-enriched uranium fuel through Framatome, factory modular fabrication with Doosan Enerbility, and first-mover credibility. It is strong on paper and unproven commercially.
The thesis fails if the TVA and ENTRA1 PPA is delayed or cancelled, RoPower financing is not secured, at-the-market dilution continues to expand the share count, litigation expands, revenue keeps falling, or the cash buffer is consumed before commercial deployment.
John Hopkins as President and CEO, Ramsey Hamady as CFO, co-founder and CTO Jose Reyes, and the board have kept about $1.0 to $1.2 billion of liquidity and target operational cash flow positive by end of 2026, but securities class action and derivative litigation over ENTRA1 disclosures is a governance and disclosure overhang.
SMR demand is tied to rising 24/7 clean baseload power needs from electrification, data centers, and industrial heat, with supportive US Japan and South Korea investment frameworks and growing commercial deal flow, but deployment cycles remain long and project financing is still the gating factor.
At $9.01 the stock trades at about 176.39x TTM sales, 2.50x book value, and about $2.42 of net cash per share on the current share count. The analyst consensus is Hold with an average target of $14.57, so the margin of safety depends on project execution, not current earnings.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| SMR price | $9.01 at the August 3, 2026, 4:00 PM EDT market close, up 0.59 or 7.01% from the $8.42 July 31 close, after opening at $8.47 and trading in a session range of $8.29 to $9.13, with an after-hours quote of $9.05 up 0.04 or 0.44% | StockAnalysis.com real-time quote and daily price history | August 4, 2026 |
| Market capitalization | Near $3.29 billion, reported by StockAnalysis.com at the August 3 market close and matching the $9.01 price times 365.48 million shares outstanding | StockAnalysis.com quote and statistics | August 4, 2026 |
| Shares outstanding | 365.48 million on StockAnalysis.com statistics, with the Q1 2026 Form 10-Q cover listing 323,741,458 Class A shares and 19,375,371 Class B shares outstanding as of March 31, 2026; shares outstanding rose 101.11% year over year | StockAnalysis.com statistics and NuScale Q1 2026 Form 10-Q | August 4, 2026 |
| TTM revenue | $18.67 million over the trailing twelve months ended March 31, 2026, down 61.9% year over year, matching StockAnalysis.com financials and Macrotrends | StockAnalysis.com financials and Macrotrends | August 4, 2026 |
| FY2025 revenue | $31.48 million, down 15.02% from $37.05 million in FY2024, matching SEC EDGAR XBRL, StockAnalysis.com, and Macrotrends | NuScale FY2025 Form 10-K, StockAnalysis.com financials, and Macrotrends | August 4, 2026 |
| TTM net loss | $385.80 million over the trailing twelve months ended March 31, 2026, versus a FY2025 net loss of $355.79 million and a FY2024 net loss of $136.62 million | StockAnalysis.com income statement | August 4, 2026 |
| Q1 2026 results | Revenue of $0.565 million versus $13.375 million in Q1 2025, loss from operations of $57.5 million, net loss of $46.7 million, net loss attributable to Class A stockholders of $44.0 million, and basic and diluted loss per share of $0.14 | NuScale Q1 2026 Form 10-Q and earnings call | August 4, 2026 |
| Cash and short-term investments | $890.13 million as of March 31, 2026, comprising $341.13 million of cash and $549.00 million of short-term investments, with SEC EDGAR XBRL reporting cash and restricted cash of $346.229 million; total cash, investments, and restricted cash near $1.0 billion, with liquidity above $1.2 billion by early May 2026 | NuScale Q1 2026 Form 10-Q, StockAnalysis.com balance sheet, and SEC EDGAR XBRL | August 4, 2026 |
| Total debt | $5.68 million reported by StockAnalysis.com, essentially no debt, with net cash of $884.45 million or about $2.42 per share on the current share count | StockAnalysis.com statistics and balance sheet | August 4, 2026 |
| 2026 at-the-market program | A 2026 ATM sales agreement entered February 26, 2026 for up to about $1.0 billion of Class A common stock with roughly $962 million of capacity remaining as of March 31, 2026, after Q1 2026 sales of about 3.2 million shares for about $37.9 million in gross proceeds | NuScale Q1 2026 Form 10-Q | August 4, 2026 |
| Analyst consensus | Hold with an average price target of $14.57 across 18 analysts, low $6.00, median $13.00, and high $25.00, about 61.71% above the current price | StockAnalysis.com forecast | August 4, 2026 |
| Analyst rating mix, July 2026 | 5 Strong Buy, 1 Buy, 10 Hold, 1 Sell, and 1 Strong Sell out of 18 analysts | StockAnalysis.com forecast recommendation trends | August 4, 2026 |
| Recent analyst target updates | Barclays lowered its target to $11 from $15 on July 22 with a Hold, Citi raised to $7.50 from $7 on July 22 with a Sell, RBC Capital maintained $14 on July 18 with a Hold, Goldman Sachs lowered to $6 from $9 on July 15 with a Hold, and Truist initiated at $10 with a Hold on July 13 | StockAnalysis.com forecast and ratings | August 4, 2026 |
| Short interest | 70.48 million shares short, 19.28% of shares outstanding, 20.77% of float, and 2.28 days to cover | StockAnalysis.com statistics short selling | August 4, 2026 |
| 52-week range and performance | 52-week range $7.21 to $57.42, down 79.72% over the trailing 52 weeks, beta 2.25 | StockAnalysis.com quote and statistics | August 4, 2026 |
| Technical snapshot | 5-day moving average near $8.37 and 20-day moving average near $8.45 computed from StockAnalysis.com daily price history, 50-day moving average near $9.94 and 200-day moving average near $16.25 on StockAnalysis.com statistics, 14-day RSI near 50.73, 20-day average volume near 29.6 million shares | StockAnalysis.com statistics and daily price history | August 4, 2026 |
| TVA and ENTRA1 project | TVA announced a non-binding agreement on September 2, 2025 with ENTRA1 to develop up to 6 GW of new nuclear power using NuScale SMR technology; management said on the Q1 2026 call that discussions were advancing toward a definitive power purchase agreement and that TVA coming across the line later in 2026 was a strong possibility | NuScale Q1 2026 Form 10-Q and Q1 2026 earnings call | August 4, 2026 |
| RoPower project | The Romanian Government approved the investment decision for the Doicesti SMR plant on February 12, 2026, allowing the project to seek financing for further feasibility studies and site-specific design before construction; the next phase is expected to last about 15 months if pre-EPC financing is secured, with Fluor as primary contractor and NuScale as subcontractor | NuScale Q1 2026 Form 10-Q and earnings call | August 4, 2026 |
| Regulatory position | NuScale is the only SMR company with full NRC standard design approval, for 50 MW and 77 MW modules under 10 CFR Part 52, and has NRC approval for behind-the-meter operations with an emergency planning zone limited to the plant site boundary | NuScale Q1 2026 earnings call | August 4, 2026 |
| Litigation | A securities class action, Truedson v. NuScale Power Corporation, was filed February 18, 2026 in the District of Oregon over alleged misstatements about ENTRA1, covering purchasers between May 13, 2025 and November 6, 2025, a derivative suit was filed March 24, 2026, and Grabar Law Office announced a shareholder investigation on May 15, 2026 | NuScale Q1 2026 Form 10-Q and press releases | August 4, 2026 |
| Upcoming catalyst | Q2 2026 earnings scheduled after market close on August 5, 2026, one day after this data cutoff | StockAnalysis.com quote earnings date | August 4, 2026 |
This SMR AI stock analysis page is an informational research tool only. It is not investment advice, a recommendation, or a promise of future returns. Forecast scenarios are based on available data as of the stated cutoff date, may be incomplete, and can be wrong after new earnings, project financing news, dilution, litigation, market moves, or macro conditions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
